Login
Register
My Saved
My Account
Cart (
)
Log Out
My Saved
Topics
Acute Myelogenous Leukemia
Biosimilars
Bladder Cancer
Brain Cancer
Breast Cancer
Chronic Lymphocytic Leukemia
Chronic Myelogenous Leukemia
Gastrointestinal Cancers
Head and Neck Cancer
Hematologic Malignancies
Hodgkin Lymphoma
Immunotherapy
All of Immunotherapy
Lung cancer
Melanoma
Head and Neck Cancer
Bladder Cancer
Hodgkin Lymphoma
Hematologic Malignancies
Adverse Event Management
Lung Cancer
Melanoma
Multiple Myeloma
Myelodysplastic Syndrome
Myeloproliferative Neoplasms
Non-Hodgkin Lymphoma
Non-Melanoma Skin Cancer
All of Non-Melanoma Skin Cancer
Squamous Cell
Basal Cell
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Renal Cell Carcinoma
Sarcoma
Faculty Contributors
Educational Tools
Toggle navigation
Acute Myelogenous Leukemia
Biosimilars
Bladder Cancer
Brain Cancer
Breast Cancer
Chronic Lymphocytic Leukemia
Chronic Myelogenous Leukemia
Gastrointestinal Cancers
Head and Neck Cancer
Hematologic Malignancies
Hodgkin Lymphoma
Immunotherapy
All of Immunotherapy
Lung cancer
Melanoma
Head and Neck Cancer
Bladder Cancer
Hodgkin Lymphoma
Hematologic Malignancies
Adverse Event Management
Lung Cancer
Melanoma
Multiple Myeloma
Myelodysplastic Syndrome
Myeloproliferative Neoplasms
Non-Hodgkin Lymphoma
Non-Melanoma Skin Cancer
All of Non-Melanoma Skin Cancer
Squamous Cell
Basal Cell
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Renal Cell Carcinoma
Sarcoma
Faculty Contributors
Educational Tools
Educational Tools
Educational Tools For Your Clinical Practice
For downloadable handouts and online resources, visit below.
Biosimilars
FDA’s Overview of the Regulatory Guidance for the Development and Approval of Biosimilar Products in the US
Biosimilar Product Information
Prescribing Biosimilar and Interchangeable Products
Breast Cancer
CDK4/6 inhibition in breast cancer: current practice and future directions
Endocrine Therapy for Hormone Receptor–Positive Metastatic Breast Cancer
History and future of targeting cyclin-dependent kinases in cancer therapy
Targeting the cyclin-dependent kinases (CDK) 4/6 in estrogen receptor-positive breast cancers
Breast Cancer Treatment – Patient Information
Colorectal Cancer
ESMO Consensus Guidelines for the Management of Patients with Metastatic Colorectal Cancer
ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer Syndromes
Screening for Colorectal Cancer US Preventive Services Task Force Recommendation Statement
BASIC (BLI Adenoma Serrated International Classification) classification for colorectal polyp characterization with blue light imaging
The adenoma miss rate of blue-laser imaging vs. white-light imaging during colonoscopy
Magnifying endoscopy simple diagnostic algorithm for early gastric cancer (MESDA-G).
Adenoma detection rate: in search of quality improvement, not just measurement
Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology
Genetic/Familial High-Risk Assessment: Colorectal v3.2017
Microsatellite Instability - Defective DNA Mismatch Repair: ESMO Biomarker Factsheet
DNA Mismatch Repair Deficiency in Rectal Cancer: Benchmarking Its Impact on Prognosis, Neoadjuvant Response Prediction, and Clinical Cancer Genetics
Get Tested for Colon Cancer [video for patients]
National Cancer Institute: Colorectal Cancer [patient version]
National Cancer Institute: Colorectal Cancer [health professional version]
National Cancer Institute: Drugs Approved for Colon and Rectal Cancer
Head and Neck Cancer
The value of immunotherapy in head and neck cancer
Blue Laser Imaging-Bright Improves Endoscopic Recognition of Superficial Esophageal Squamous Cell Carcinoma
Molecular Interactions and Expression of PD-1 and PD-L1
Checkpoint Inhibitors Targeting PD-1 vs PD-L1
Hematologic Malignancies
Multiple Myeloma Disease Overview
Multiple Myeloma – Treatment Overview for Patients and Caregivers
Stem Cell Transplantation for Multiple Myeloma – for Patients
Treatment for Multiple Myeloma – for Health Professionals
World Federation of Hemophilia Guidelines for the Management of Hemophilia
Hemophilia
World Federation of Hemophilia Guidelines for the Management of Hemophilia
Hepatocellular carcinoma
Hepatocellular Carcinoma: ESMO-ESDO Clinical Practice Guidelines
Locoregional Therapy for Hepatocellular Carcinoma with and without Extrahepatic Spread
NCCN. Hepatobiliary Cancers v4. 2017
Multidisciplinary approach for HCC patients: hepatology for the oncologists
Leukemia
Rai and Binet Systems for Clinical Staging of CLL
Lung Cancer
Molecular Interactions and Expression of PD-1 and PD-L1
Checkpoint Inhibitors Targeting PD-1 vs PD-L1
Melanoma
Nivolumab Nurses’ Checklist
Ipilimumab Nurses’ Checklist
Melanoma Treatment – for health professionals
Melanoma Risk Assessment Tool
Patients Educational Tool – Skin Cancer: Frequently Asked Question
Molecular Interactions and Expression of PD-1 and PD-L1
Checkpoint Inhibitors Targeting PD-1 vs PD-L1
Combination Therapy: Nivolumab + Ipilimumab
Immunotherapy for Melanoma Skin Cancer
Targeted Therapy for Melanoma
Myelodysplastic Syndromes
About Myelodysplastic Syndromes (MDS)
Detailed Guide on MDS
How are myelodysplastic syndromes staged?
Treating MDS Toolkit
The Diagnostic Spectrum of MDS, MDS/MPN, and MF Reference Card
What is MDS? iPad App
Non-Small Cell Lung Cancer (NSCLC)
Article: NCCN Guidelines Insights: Malignant Pleural Mesothelioma
Biomarker discussion in National Comprehensive Cancer Network (NCCN) Quick Guide for Lung Cancer
National Comprehensive Cancer Network (NCCN) Guidelines for Treatment of Cancer by Site
Patients Educational Tool ─ Lung Cancer: Frequently Asked Questions
Lung Cancer Screening Guidelines and Recommendations
Questions to Ask Your Doctor: Non-Small Cell Lung Cancer - Patient Handout
Understanding Non-Small Cell Lung Cancer - Patient Handout
×
Close
Notice